Mechanistically, treatment with SIS3 was able to inactivate Smad3 signaling specifically and effectively and thus blocked p21‐dependent G1 cell cycle arrest and inhibited SARS‐CoV‐2 N‐induced TEC death and AKI. The gene discussed is SMAD3; the disease is acute kidney injury.